We are live on ! Find out more
GAA

Green Alpha Advisors Portfolio holdings

AUM $102M
1-Year Est. Return 59.84%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+59.84%
3 Year Est. Return
+135.67%
5 Year Est. Return
+165.06%
10 Year Est. Return
AUM
$125M
AUM Growth
-$2.66M
Cap. Flow
-$1.21M
Cap. Flow %
-0.97%
Top 10 Hldgs %
22.98%
Holding
151
New
10
Increased
38
Reduced
98
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 42.96%
2 Real Estate 17.17%
3 Healthcare 9.05%
4 Consumer Discretionary 7.41%
5 Consumer Staples 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIO icon
126
NIO
NIO
$11.6B
$202K 0.16%
46,295
-27,118
-37% -$138K
BEEM icon
127
Beam Global
BEEM
$23.3M
$190K 0.15%
59,982
+13,162
+28% +$54.1K
PRME icon
128
Prime Medicine
PRME
$544M
$188K 0.15%
+64,406
New +$226K
PACB icon
129
Pacific Biosciences
PACB
$422M
$187K 0.15%
102,421
+38,208
+60% +$74.6K
ECX icon
130
ECARX Holdings
ECX
$424M
$167K 0.13%
+78,996
New +$146K
VERV
131
DELISTED
Verve Therapeutics
VERV
$166K 0.13%
29,438
+3,840
+15% +$21.7K
WOLF icon
132
Wolfspeed
WOLF
$1.24B
$150K 0.12%
22,574
-11,794
-34% -$120K
GWH icon
133
ESS Tech
GWH
$22.6M
$147K 0.12%
24,933
-92
-0.4% -$614
SOPH icon
134
SOPHiA GENETICS
SOPH
$474M
$145K 0.12%
47,216
+25,686
+119% +$87.4K
SHLS icon
135
Shoals Technologies Group
SHLS
$1.57B
$143K 0.11%
25,851
-14,785
-36% -$75K
CMPS
136
Compass Pathways
CMPS
$1.52B
$142K 0.11%
37,614
+21,833
+138% +$111K
EDIT icon
137
Editas Medicine
EDIT
$411M
$142K 0.11%
111,628
+68,295
+158% +$174K
DNA icon
138
Ginkgo Bioworks
DNA
$487M
$138K 0.11%
14,021
-2,233
-14% -$19.1K
NTLA icon
139
Intellia Therapeutics
NTLA
$1.49B
$138K 0.11%
+11,799
New +$184K
INO icon
140
Inovio Pharmaceuticals
INO
$79.4M
$120K 0.1%
65,446
+33,232
+103% +$147K
ABCL icon
141
AbCellera Biologics
ABCL
$1.6B
$111K 0.09%
37,835
-10,680
-22% -$29.7K
LICY
142
DELISTED
Li-Cycle Holdings Corp.
LICY
$109K 0.09%
60,642
-5,232
-8% -$11.3K
ARRY icon
143
Array Technologies
ARRY
$848M
$92.2K 0.07%
15,273
-16,925
-53% -$108K
CVAC
144
DELISTED
CureVac
CVAC
$88.8K 0.07%
26,037
-1,282
-5% -$3.7K
MGX icon
145
Metagenomi Therapeutics
MGX
$45.6M
$87.5K 0.07%
24,230
-7,463
-24% -$18K
OMGA
146
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$35.5K 0.03%
47,647
-14,914
-24% -$14.9K
PSNY icon
147
Polestar Automotive Holding UK
PSNY
$2.04B
$12.4K 0.01%
393
-6,324
-94% -$229K
ENVX icon
148
Enovix
ENVX
$923M
-36,341
Closed -$297K
GGR icon
149
Gogoro
GGR
$69.9M
-2,438
Closed -$25.8K
MAXN
150
DELISTED
Maxeon Solar Technologies
MAXN
-318
Closed -$3.08K

Similar funds

Green Alpha Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Green Alpha Advisors held 151 positions worth $125M, down 2.1% from $127M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Green Alpha Advisors's Q4 2024 filing shows 10 new, 38 increased, 98 reduced and 4 closed positions. Its largest new stake was Tempus AI: 32,283 shares worth $1.09M. The largest sale was Vornado Realty Trust, an estimated $1.15M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 45% a quarter earlier, followed by Real Estate and Healthcare.

  • Green Alpha Advisors's largest Q4 2024 buy was Tempus AI: 32,283 shares worth $1.09M.
  • Green Alpha Advisors added most to Brookfield Renewable in Q4 2024, an estimated $1.53M increase.
  • Green Alpha Advisors's biggest Q4 2024 reduction was Vornado Realty Trust, cutting an estimated $1.15M.
  • Green Alpha Advisors fully exited Primo Water Corporation in Q4 2024, selling an estimated $693K.
  • Green Alpha Advisors's ten largest holdings make up 23% of its $125M portfolio in Q4 2024.
  • Green Alpha Advisors opened 10 new positions and closed 4 in Q4 2024.
  • Green Alpha Advisors's portfolio value fell 2.1% quarter-over-quarter to $125M.

Based on Green Alpha Advisors's 13F filing for Q4 2024, filed 13 Jan 2025.